Simultaneous extraction and combined bioluminescent assay of NAD+ and NADH.

M. Karp,R. Raunio,T. Lövgren

DOI: https://doi.org/10.1016/0003-2697(83)90359-7

IF: 2.9

Analytical Biochemistry

Abstract:

What problem does this paper attempt to address?

P27 Successful treatment of severe eczema and plane warts with Dupilumab in a child with Dedicator of Cytokinesis 8 (DOCK8) deficiency (Autosomal recessive form of hyper-IgE syndrome)

Jadesola Oyedepo,Austen Worth,Lea Solman

DOI: https://doi.org/10.1093/bjd/ljad483.035

IF: 11.113

2024-01-01

British Journal of Dermatology

Abstract:Abstract A six-year-old girl first presented with severe eczema at the age of 6 months, which was difficult to control with topical treatments. She was found to have severely elevated total IgE and multiple food allergies. Due to recurrent ear and chest infections, and persistent varicella zoster, she was screened for a primary immunodeficiency and found to have a homozygous exon 29-46 deletion in the DOCK8 gene. Her eczema remained challenging, with coalescing warts on her limbs. She started Methotrexate with an initial good response; however, the frequency of infections and hospitalizations increased. After the diagnosis of DOCK8 deficiency was confirmed, she started Dupilumab, resulting in the complete resolution of her eczema and warts. She is awaiting haematopoietic stem cell transplant (HSCT) . DOCK8 deficiency is an autosomal recessive hyper-IgE syndrome that presents early in life with severe eczema, skin abscesses, multiple food allergies, recurrent respiratory tract infections, and severe viral (including skin) infections. Older patients invariably develop bronchiectasis and are at high risk of malignancy. Patients have a combined immunodeficiency, with T-cell lymphopenia, reduced thymic output and T-cell skewing to a Th2 response. Children with this condition often present to dermatologists because of severe eczema, which is usually difficult to treat with standard topical treatments. The decision to treat with systemic immunosuppression is often challenging due to recurrent infections. Although HSCT is the curative treatment for DOCK8 deficiency, Dupilumab can be used to reduce inflammation and infections, and improve quality of life in patients awaiting HSCT.

dermatology
Effect of Local Competition on the Willingness of Community Pharmacies to Supply Medication Therapy Management Services

J. Brooks,D. Klepser,J. Urmie,K. Farris,W. Doucette

DOI: https://doi.org/10.1177/107937390703000106

2007-03-01

Journal of Health and Human Services Administration

Abstract:The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) provides a prescription drug benefit for Medicare-eligible seniors that includes access to medication therapy management services (MTMS) through pharmacists. We theorize that local community pharmacy market competition affects the decision of individual community pharmacies to provide MTMS. Our model suggests that MTMS services are more apt to be supplied in markets at the extremes of community pharmacy concentration (very low and very high). We found that local community pharmacy competition affected the service choices made by the pharmacy decision-makers willing to provide MTMS in a manner consistent with our theory. As a result, patient access to MTMS services depends on both (1) patient access to pharmacies willing to provide MTMS and (2) the level of local community pharmacy competition.
Dedicator of cytokinesis 8 (DOCK8) mutation impairs the differentiation of helper T cells by regulating the glycolytic pathway of CD4+ T cells

Panpan Jiang,Siyu Zhao,Xiaoyu Li,Shiyan Hu,Shuhan Chen,Yinming Liang,Lichen Zhang,Liaoxun Lu,Guofeng Fang,Lu Yang,Yanmei Huang,Heather Miller,Fei Guan,Jiahui Lei,Chaohong Liu

DOI: https://doi.org/10.1002/mco2.747

2024-09-25

Abstract:Dedicator of cytokinesis 8 (DOCK8) deficiency is a primary immunodeficiency disease caused by mutations in exon 45 of the DOCK8 gene. The clinical signs primarily consist of increased serum IgE levels, eczema, repeated skin infections, allergies, and upper respiratory tract infections. Using CRISPR/Cas9 technology, we generated a DOCK8 exon 45 mutation in mice, mirroring the mutation found in patients. The results indicated that DOCK8 mutation impairs peripheral T cell homeostasis, disrupts regulatory T cells (Tregs) development, increases ICOS expression in Tregs within peripheral lymph nodes (pLn), and promotes Th17 cell differentiation within the spleen and pLn. Upon virus infection, DOCK8 mutation CD4+ T cells have a Th2 effector fate. RNA-bulk sequencing data revealed alternations in the mTOR pathway of DOCK8 mutant CD4+ T cells. We observed that DOCK8 mutation upregulates the glycolysis levels in CD4+ T cells, which is related to the Akt/mTOR/S6/HIF-1α pathway. In summary, our research elucidates that DOCK8 regulates the differentiation of helper T cells by modulating the glycolytic pathway in CD4+ T cells, thereby advancing the comprehension and offering potential treatment of diseases in DOCK8-deficient patients.
Clinical, immunological, and genetic description of a Mexican cohort of patients with DOCK8 deficiency

Eduardo Liquidano‐Perez,Gibert Maza‐Ramos,Bethy Alexandra Perez Arias,Saul Oswaldo Lugo Reyes,Tania Barragan Arevalo,Sara Alejandra Solorzano‐Morales,Edna Venegas Montoya,Aidé Tamara Staines‐Boone,Rogelio Guzmán Cotaya,Satoshi Okada,Capucine Picard,Etienne Patin,Nideshda Ramirez‐Uribe,Juan Carlos Bustamante‐Ogando,Selma Cecilia Scheffler‐Mendoza,Marco Antonio Yamazaki‐Nakashimada,Marimar Saez‐de‐Ocariz,Sara Elva Espinosa Padilla,Maria Edith Gonzalez‐Serrano

DOI: https://doi.org/10.1111/pai.14073

2024-02-16

Pediatric Allergy and Immunology

Abstract:Purpose We aimed to describe the clinical, immunological, and genetic features of patients with DOCK8 deficiency (DOCK8‐Def) in a tertiary care center for children. Methods Retrospective chart review of patients' clinical, immunological, and genetic characteristics with DOCK8‐Def. Genetic analysis was performed with targeted‐ or whole‐exome sequencing; we also assessed DOCK8 protein expression and a lymphoproliferation assay and analyzed survival by the Kaplan–Meier method. Results We described 11 patients from 8 unrelated kindreds. The median age at symptoms' onset was 10 months (range 1–54 months). The median follow‐up time was 53.4 months (4.8–118.8). All patients presented eczema and recurrent sinopulmonary and cutaneous infections. Besides those symptoms, the most frequent manifestations were bronchiectases (8/11), food allergies (6/11), and severe infections (6/11). Infrequent characteristics were detection of CMV in bronchial lavage, C. parvum‐driven sclerosing cholangitis, Takayasu vasculitis, neurological syndromes, pulmonary tuberculosis, and lymphomatoid granulomatosis. Conclusion DOCK8‐Def has a broad spectrum of manifestations, including allergy, autoimmunity, inflammation, infection, and cancer. The hallmark of this inborn error of immunity is IEI‐associated eczema with eosinophilia and increased IgE. Here, we report six new mutations causing human DOCK8 deficiency and symptoms previously unrecognized to occur in DOCK8‐Def. Therefore, an early diagnosis of DOCK8‐Def is essential to facilitate an adequate treatment such as HSCT.

pediatrics,immunology,allergy
The Protein Kinase C βII Exon Confers mRNA Instability in the Presence of High Glucose Concentrations*

N. Patel,D. Eichler,D. Chappell,P. Illingworth,C. Chalfant,Mayumi Yamamoto,N. Dean,J. Wyatt,K. Mebert,J. Watson,D. Cooper

DOI: https://doi.org/10.1074/JBC.M206797200

IF: 5.485

2003-01-10

Journal of Biological Chemistry

Abstract:Previous studies showed that short term exposure of cells to high glucose destabilized protein kinase C (PKC) βII mRNA, whereas PKCβI mRNA levels remained unaltered. Because PKCβ mRNAs share common sequences other than the PKCβII exon encoding a different carboxyl terminus, we examined PKCβII mRNA for a cis-acting region that could confer glucose-induced destabilization. A β-globin/growth hormone reporter con struct containing the PKCβII exon was transfected into human aorta and rat vascular smooth muscle cells (A10) to follow glucose-induced destabilization. Glucose (25 mm) exposure destabilized PKCβII chimeric mRNA but not control mRNA. Deletion analysis and electrophoretic mobility shift assays followed by UV cross-linking experiments demonstrated that a region introduced by inclusion of the βII exon was required to confer destabilization. Although a cis-acting element mapped to 38 nucleotides within the βII exon was necessary to bestow destabilization, it was not sufficient by itself to confer complete mRNA destabilization. Yet, in intact cells antisense oligonucleotides complementary to this region blocked glucose-induced destabilization. These results suggest that this region must function in context with other sequence elements created by exon inclusion involved in affecting mRNA stability. In summary, inclusion of an exon that encodes PKCβII mRNA introduces a cis-acting region that confers destabilization to the mRNA in response to glucose.
DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients

Susanne E. Aydin,,Sara Sebnem Kilic,Caner Aytekin,Ashish Kumar,Oscar Porras,Leena Kainulainen,Larysa Kostyuchenko,Ferah Genel,Necil Kütükcüler,Neslihan Karaca,Luis Gonzalez-Granado,Jordan Abbott,Daifulah Al-Zahrani,Nima Rezaei,Zeina Baz,Jens Thiel,Stephan Ehl,László Marodi,Jordan S. Orange,Julie Sawalle-Belohradsky,Sevgi Keles,Steven M. Holland,Özden Sanal,Deniz C. Ayvaz,Ilhan Tezcan,Hamoud Al-Mousa,Zobaida Alsum,Abbas Hawwari,Ayse Metin,Susanne Matthes-Martin,Manfred Hönig,Ansgar Schulz,Capucine Picard,Vincent Barlogis,Andrew Gennery,Marianne Ifversen,Joris van Montfrans,Taco Kuijpers,Robbert Bredius,Gregor Dückers,Waleed Al-Herz,Sung-Yun Pai,Raif Geha,Gundula Notheis,Carl-Philipp Schwarze,Betül Tavil,Fatih Azik,Kirsten Bienemann,Bodo Grimbacher,Valerie Heinz,H. Bobby Gaspar,Roland Aydin,Beate Hagl,Benjamin Gathmann,Bernd H. Belohradsky,Hans D. Ochs,Talal Chatila,Ellen D. Renner,Helen Su,Alexandra F. Freeman,Karin Engelhardt,Michael H. Albert,

DOI: https://doi.org/10.1007/s10875-014-0126-0

IF: 8.542

2015-01-28

Journal of Clinical Immunology

Abstract:Mutations in DOCK8 result in autosomal recessive Hyper-IgE syndrome with combined immunodeficiency (CID). However, the natural course of disease, long-term prognosis, and optimal therapeutic management have not yet been clearly defined. In an international retrospective survey of patients with DOCK8 mutations, focused on clinical presentation and therapeutic measures, a total of 136 patients with a median follow-up of 11.3 years (1.3–47.7) spanning 1693 patient years, were enrolled. Eczema, recurrent respiratory tract infections, allergies, abscesses, viral infections and mucocutaneous candidiasis were the most frequent clinical manifestations. Overall survival probability in this cohort [censored for hematopoietic stem cell transplantation (HSCT)] was 87 % at 10, 47 % at 20, and 33 % at 30 years of age, respectively. Event free survival was 44, 18 and 4 % at the same time points if events were defined as death, life-threatening infections, malignancy or cerebral complications such as CNS vasculitis or stroke. Malignancy was diagnosed in 23/136 (17 %) patients (11 hematological and 9 epithelial cancers, 5 other malignancies) at a median age of 12 years. Eight of these patients died from cancer. Severe, life-threatening infections were observed in 79/136 (58 %); severe non-infectious cerebral events occurred in 14/136 (10 %). Therapeutic measures included antiviral and antibacterial prophylaxis, immunoglobulin replacement and HSCT. This study provides a comprehensive evaluation of the clinical phenotype of DOCK8 deficiency in the largest cohort reported so far and demonstrates the severity of the disease with relatively poor prognosis. Early HSCT should be strongly considered as a potential curative measure.

immunology
A novel homozygous DOCK8 mutation associated with unusual coexistence of gross molluscum contagiosum and epidermodysplasia verruciformis in a DOCK8 deficiency patient.

Y-Q Liu,G-L Zhang,X-H Mo,B Wang,F Wu,J Chen,H Luo,L-D Zhu,M-Y Xu,Q Zhou,Q-L Cai,X-L Wang

DOI: https://doi.org/10.1111/jdv.14344

2017-01-01

Journal of the European Academy of Dermatology and Venereology

Abstract:Dedicator of cytokinesis 8 (DOCK8) deficiency is a primary immunodeficiency, caused by biallelic loss-of-function mutations in the DOCK8 gene, often leading to severe viral infections, but do not usually have epidermodysplasia verruciformis (EV).1,2 Here we report a Chinese patient with unusual coexistence of gross generalized molluscum contagiosum (MC) and EV.This article is protected by copyright. All rights reserved.
Single-Cell Transcriptomics Reveals a Pivotal Role of DOCK2 in Sjögren Disease

Yiran Shen,Alexandria Voigt,Indraneel Bhattacharyya,Cuong Q Nguyen

DOI: https://doi.org/10.1002/acr2.11738

2024-10-09

Abstract:Objective: Sjögren disease (SjD) is an autoimmune condition characterized by the dysfunction of the salivary and lacrimal glands. The study aimed to decipher the pathogenic cell populations and their immunologic pathways in the salivary glands. We further determined the therapeutic effect of inhibiting dedicator of cytokinesis 2 (DOCK2) shared by novel clusters of CD8+ T cells in an SjD mouse model. Methods: This study employed single-cell RNA sequencing to examine the composition and dynamics of immune cells in the salivary glands of SjD mice. By analyzing the transcriptomic data and employing clustering analysis, a specific target was identified, leading to the treatment of mice with a targeted inhibitor. Results: The results showed diverse immune cell types, including B cells, CD4+ T cells, CD8+ T cells, macrophages, and natural killer cells. We identified specific clusters possessing phenotypic characteristics of immune cell subpopulations, thereby showing specific genes/pathways associated with the disease. The most striking finding was the elevated expression of DOCK2 in CD8+ T cells in the SjD model. This discovery is significant because subsequent treatment with a DOCK2 inhibitor 4-[3-(2-Chlorophenyl)-2-propen-1-ylidene]-1-phenyl-3,5-pyrazolidinedione (CPYPP) led to a marked amelioration of SjD signs. Conclusion: The effectiveness of DOCK2 inhibition in alleviating SjD signs highlights the potential of DOCK2 as a therapeutic target, opening new avenues for treatment strategies that could modulate the immune response more effectively in SjD.
DOCK8 Mutation in Patient with Juvenile Idiopathic Arthritis and Sjögren's Syndrome

Violetta Opoka-Winiarska,Natalia Winiarska,Monika Lejman,Małgorzata Gdak,Krzysztof Gosik,Filip Lewandowski,Paulina Niedźwiedzka-Rystwej,Ewelina Grywalska

DOI: https://doi.org/10.3390/ijms25042259

IF: 5.6

2024-02-14

International Journal of Molecular Sciences

Abstract:This study investigated the association between autoimmunity and immunodeficiency in pediatric patients, focusing on the case of a 15-year-old female diagnosed with juvenile idiopathic arthritis (JIA) and secondary Sjögren's syndrome. The patient presented with a variety of symptoms, including joint pain, bronchial asthma, leukopenia, and skin lesions. Genetic testing revealed a de novo mutation in the DOCK8 gene, associated with DOCK8 deficiency, a condition usually associated with immunodeficiencies. The clinical course, diagnostic pathway, and treatment history are detailed, highlighting the importance of molecular diagnostics in understanding the genetic basis of rheumatic diseases. This case highlights the need to consider innate immune errors in patients with multiple diseases or atypical symptoms of rheumatic diseases. Furthermore, the study highlights the importance of targeted treatment, including genetic counseling, to improve patient outcomes. The observed association between autoimmunity and immune deficiency reinforces the importance of molecular testing in elucidating the causes of previously idiopathic rheumatic diseases, contributing to improved patient care and quality of life.

biochemistry & molecular biology,chemistry, multidisciplinary
Characterization and cloning of an (R)-specific trans-2,3-enoylacyl-CoA hydratase from Rhodospirillum rubrum and use of this enzyme for PHA production in Escherichia coli

S. Reiser,T. Mitsky,K. Gruys

DOI: https://doi.org/10.1007/s002530050010

IF: 5

2000-02-01

Applied Microbiology and Biotechnology

Abstract:
Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy

Yu Zhu,Lili Ye,Hua Huang,Xuemei Xu,Yu Liu,Jian Wang,Yanliang Jin

DOI: https://doi.org/10.3389/fped.2022.1042302

2023-01-16

Abstract:Capping protein regulator and myosin 1 linker 2 (CARMIL2) is necessary for invadopodia formation, cell polarity, lamellipodial assembly, membrane ruffling, acropinocytosis, and collective cell migration. CARMIL2 deficiency is a rare autosomal recessive disease characterized by dysfunction in naïve T-cell activation, proliferation, differentiation, and effector function and insufficient responses in T-cell memory. In this paper, we report a 9-year-old female patient with a novel pathogenic variant in CARMIL2 (c.2063C > G:p.Thr688Arg) who presented with various symptoms of primary immunodeficiencies including recurrent upper and lower respiratory infections, perioral and perineum papules, reddish impetiginized atopic dermatitis, oral ulcer, painful urination and vaginitis, otitis media, and failure to thrive. A missense mutation leading to insufficient CARMIL2 protein expression, reduced absolute T-cell and natural killer cell (NK cell) counts, and marked skewing to the naïve T-cell form was identified and indicated defective maturation of T cells and B cells. Following 1 year of multitargeted treatment with corticosteroids, hydroxychloroquine, mycophenolate mofetil, and thymosin, the patient presented with significant regression in rashes. CD4+ T-cell, CD8+ T-cell, and NK cell counts were significantly improved.
Hyper-IgE Syndrome Caused by DOCK8 Mutation with a Tumour-Like Lesion of the Lip: a Case Report

W.-X. Zhu,Y.-Y. Liu,H. Hua,G.-Y. Yu

DOI: https://doi.org/10.1016/j.ijom.2022.03.055

IF: 2.986

2022-01-01

International Journal of Oral and Maxillofacial Surgery

Abstract:Autosomal recessive hyper-IgE syndrome caused by DOCK8 gene mutation is an immunodeficiency. However, the presentation of a tumour-like lesion of the lip in autosomal recessive hyper-IgE syndrome has not yet been reported. This article reports the case of a 20-year-old man with autosomal recessive hyper-IgE syndrome who presented with a tumour-like lesion of the lip, and hyperplasia and erosion of the gingiva. The clinical manifestations included coarse face and neck skin, a diffuse tumour-like lesion on the upper lip showing a reddish erosive nodular surface with yellowish-white exudation, erosive buccal mucosa, and severe periodontitis. The swollen gingival and palatal mucosa indicated nodular hyperplasia and redness with pseudomembrane. The patient had a significantly increased peripheral blood eosinophil count and serum IgE level and an abnormal T lymphocyte count. His oral lesions improved markedly after prednisolone acetate use and local symptomatic treatment for 2 years. However, the patient unfortunately died of a cerebral infection 6 months after the oral lesions had resolved. The novel features of the labial tumour-like lesion described here extend our understanding of the manifestations of autosomal recessive hyper-IgE syndrome.
Role of DOCK8 in cytokine storm syndromes

Mingce Zhang,Remy R Cron,Niansheng Chu,Junior Nguyen,Scott M Gordon,Esraa M Eloseily,T Prescott Atkinson,Peter Weiser,Mark R Walter,Portia A Kreiger,Scott W Canna,Edward M Behrens,Randy Q Cron

DOI: https://doi.org/10.1016/j.jaci.2024.10.004

2024-10-17

Abstract:Background: Cytokine storm syndromes (CSSs), including hemophagocytic lymphohistiocytosis (HLH), are increasingly recognized as hyperinflammatory states leading to multiorgan failure and death. Familial HLH in infancy results from homozygous genetic defects in perforin-mediated cytolysis by CD8 T lymphocytes and natural killer (NK) cells. Later-onset CSSs are often associated with heterozygous defects in familial HLH genes, but genetic etiologies for most are unknown. We identified rare dedicator of cytokinesis 8 (DOCK8) variants in patients with CSS. Objective: We sought to explore the role of CSS patient-derived DOCK8 mutations on cytolytic activity in NK cells and to further study effects of DOCK8 deficiency in murine models of CSSs. Methods: DOCK8 cDNAs from 2 unrelated patients with CSS with different missense mutations were introduced into human NK-92 cells by foamy virus transduction. NK-cell degranulation (CD107a), cytolytic activity against K562 target cells, and IFN-γ production were explored by flow cytometry. A third patient with CSS with DOCK8 mRNA splice acceptor site variant was explored by exon trapping. Dock8-/- mice were assessed for features of CSS (weight loss, splenomegaly, hepatic inflammation, cytopenias, and IFN-γ levels) on challenge with lymphocytic choriomeningitis virus and excess IL-18. Results: Both patient DOCK8 missense mutations decreased cytolytic function in NK cells in a partial dominant-negative fashion in vitro. The patient DOCK8 splice variant disrupted mRNA splicing in vitro. Lymphocytic choriomeningitis virus infection promoted CSS in Dock8-/- mice and interacted with excess IL-18, limiting T-cell numbers while promoting CD8 T-cell hyperactivation. Conclusions: Mutations in DOCK8 may contribute to CSS-like hyperinflammatory states by altering cytolytic function in a threshold model of disease.
DOCK8 gene mutation alters cell subsets, BCR signaling, and cell metabolism in B cells

Heng Gu,Miaomiao Xie,Siyu Zhao,Xi Luo,Yanmei Huang,Lu Yang,Fei Guan,Jiahui Lei,Chaohong Liu

DOI: https://doi.org/10.1038/s41419-024-07180-w

2024-12-01

Cell Death and Disease

Abstract:DOCK8 deficiency has been shown to affect the migration, function, and survival of immune cells in innate and adaptive immune responses. The immunological mechanisms underlying autosomal recessive (AR) hyper-IgE syndrome (AR-HIES) caused by DOCK8 mutations remain unclear, leading to a lack of specific therapeutic options. In this study, we used CRISPR/Cas9 technology to develop a mouse model with a specific DOCK8 point mutation in exon 45 (c.5846C>A), which is observed in patients with AR-HIES. We then investigated the effect of this mutation on B cell development, cell metabolism, and function in a mouse model with Dock8 gene mutation. The results demonstrated that Dock8 gene mutation inhibited splenic MZ and GC B cell development and crippled BCR signaling. In addition, it resulted in enhanced glycolysis in B cells. Mechanistically, the reduced BCR signaling was related to decreased B cell spreading, BCR clustering, and signalosomes, mediated by inhibited activation of WASP. Furthermore, the DOCK8 mutation led to increased expression of c-Myc in B cells, which plays an important role in glycolysis. As such, GC B cells' formation and immune responses were disturbed in LCMV-infected mice. These findings will provide new insights into the immunological pathogenesis of primary immunodeficiency disorder caused by DOCK8 mutation.

cell biology
The role of reconstructive surgery in the management of war wounds.

C. Lavy,T. Briggs

1991-07-01

Annals of The Royal College of Surgeons of England

Abstract:
The regulation of DOCK family proteins on T and B cells

Yuanyuan Chen,Yan Chen,Wei Yin,Hong Han,Heather Miller,Jianrong Li,Andres A. Herrada,Masato Kubo,Zhiwei Sui,Quan Gong,Chaohong Liu

DOI: https://doi.org/10.1002/JLB.1MR0520-221RR

2020-06-17

Journal of Leukocyte Biology

Abstract:The dedicator of cytokinesis (DOCK) family proteins consist of 11 members, each of which contains 2 domains, DOCK homology region (DHR)‐1 and DHR‐2, and as guanine nucleotide exchange factors, they mediate activation of small GTPases. Both DOCK2 and DOCK8 deficiencies in humans can cause severe combined immunodeficiency, but they have different characteristics. DOCK8 defect mainly causes high IgE, allergic disease, refractory skin virus infection, and increased incidence of malignant tumor, whereas DOCK2 defect mainly causes early‐onset, invasive infection with less atopy and increased IgE. However, the underlying molecular mechanisms causing the disease remain unclear. This paper discusses the role of DOCK family proteins in regulating B and T cells, including development, survival, migration, activation, immune tolerance, and immune functions. Moreover, related signal pathways or molecule mechanisms are also described in this review. A greater understanding of DOCK family proteins and their regulation of lymphocyte functions may facilitate the development of new therapeutics for immunodeficient patients and improve their prognosis.

immunology,cell biology,hematology
A case of trichodysplasia spinulosa related to ruxolitinib treated successfully with oral acitretin

Priscilla M Rosa-Nieves,Robert Borucki,Corey Georgesen,Adam Sutton,Megan Arthur,Melodi Javid Whitley

DOI: https://doi.org/10.1002/ski2.276

2023-08-16

Abstract:Trichodysplasia spinulosa (TS) is a rare disease that affects immunocompromised patients, characterized by hair-like growths caused by TS-associated polyomavirus infection. Little is known about specific immunosuppressive drugs that can precipitate the condition. We report a case of TS presenting after initiating the oral Janus-associated kinase inhibitor (JAKi) ruxolitinib. A 67-year-old female with a history of allogeneic bone marrow transplant requiring immunosuppression with tacrolimus, prednisone and, more recently, ruxolitinib 5 mg twice daily due to Graft versus Host Disease presented to the clinic with a facial rash. The clinical and histopathological findings in the setting of immunosuppression were consistent with TS. Initial treatments were ineffective, but oral acitretin showed significant improvement after 3 months. Due to the close temporal relationship between the initiation of ruxolitinib and the development of TS, this case suggests that JAKis may contribute to TS development by suppressing the JAK-signal transducer and activator of the transcription pathway's antiviral functions.
Idiopathic multicentric Castleman disease and connective tissue disorder successfully treated by siltuximab: a pediatric case report

Shiwen Hu,Zifeng Li,Haiyan Zhang,Yifan Li,Jiajian Yang,Yangyang Ma,Lian Chen,Li Sun,Xiaowen Zhai

DOI: https://doi.org/10.21037/tp-23-605

2024-05-31

Translational Pediatrics

Abstract:Keywords: Castleman disease (CD); connective tissue disorder (CTD); pediatric; case report; siltuximab

pediatrics
Combined immunodeficiency with marginal zone lymphoma due to a novel homozygous mutation in IL-21R gene and successful treatment with hematopoietic stem cell transplantation

Neslihan Edeer Karaca,Gülcihan Özek,Eda Ataseven,Nazan Tökmeci,Handan Duman Şenol,Ezgi Kıran,Ayça Aykut,Asude Durmaz,Güzide Aksu,Serap Aksoylar,Sema Aydoğdu,Nazan Çetingül,Necil Kütükçüler

DOI: https://doi.org/10.1080/08880018.2021.1924326

2021-05-08

Pediatric Hematology and Oncology

Abstract:Mutations in the interleukin-21 receptor (IL-21R) gene are recently defined as primary immunodeficiency diseases. IL-21R defects result in combined immunodeficiency by affecting the functions of innate and adaptive immune system components.A six-year-old girl was admitted to our hospital with complaints of chronic diarrhea that started after the newborn period and generalized rash over the last three months. She had severe respiratory distress due to Cytomegalovirus (CMV) pneumonia requiring mechanical ventilation and was diagnosed as combined immunodeficiency at another hospital at the age of four. Her physical examination on admission revealed erythematous rash on cheeks, extremities, gluteal region, and lymph node enlargements in cervical, axillary, and inguinal regions. CMV DNA and stool Cryptosporidium parvum were positive. Marginal zone lymphoma –negative for Epstein-Bar virus– was reported in the lymph node biopsy. Targeted next-generation sequencing Ion AmpliSeq™ primary immunodeficiency panel revealed a novel homozygous IL21R c.132delC (p.Ser45fs) mutation.This case is presented to emphasize that IL21R defects should be considered in the differential diagnosis of the patients with recurrent respiratory infections, chronic diarrhea, C. parvum infection, chronic liver disease, sclerosing cholangitis, and malignancy where early hematopoietic stem cell transplantation (HSCT) is life-saving. A total of eight cases with IL21R gene defects have been reported so far. The significance of this case is that it is the first case of malignancy among the published IL-21R deficient patients successfully treated with HSCT.

oncology,pediatrics,hematology
DOCK2-deficiency causes defects in anti-viral T cell responses and impaired control of herpes simplex virus infection

Katrina L Randall,Inge E A Flesch,Yan Mei,Lisa A Miosge,Racheal Aye,Zhijia Yu,Heather Domaschenz,Natasha A Hollett,Tiffany A Russell,Tijana Stefanovic,Yik Chun Wong,Sandali Seneviratne,Fiona Ballard,Raquel Hernandez Gallardo,Sarah N Croft,Christopher C Goodnow,Edward M Bertram,Anselm Enders,David C Tscharke

DOI: https://doi.org/10.1093/infdis/jiae077

2024-02-19

The Journal of Infectious Diseases

Abstract:The expanding number of rare immunodeficiency syndromes offers an opportunity to understand key genes that support immune defence against infectious diseases. However, analysis of these in patients is complicated by their treatments and co-morbid infections requiring the use of mouse models for detailed investigations. Here we develop a mouse model of DOCK2 immunodeficiency and demonstrate that these mice have delayed clearance of herpes simplex virus type 1 (HSV-1) infections. We also uncovered a critical, cell intrinsic role of DOCK2 in the priming of anti-viral CD8 + T cells and in particular their initial expansion, despite apparently normal early activation of these cells. When this defect was overcome by priming in vitro, DOCK2-deficient CD8 + T cells were surprisingly protective against HSV-1-disease, albeit not as effectively as wild type cells. These results shed light on a cellular deficiency that is likely to impact anti-viral immunity in DOCK2-deficient patients.

immunology,infectious diseases,microbiology

Simultaneous extraction and combined bioluminescent assay of NAD+ and NADH.

P27 Successful treatment of severe eczema and plane warts with Dupilumab in a child with Dedicator of Cytokinesis 8 (DOCK8) deficiency (Autosomal recessive form of hyper-IgE syndrome)

Effect of Local Competition on the Willingness of Community Pharmacies to Supply Medication Therapy Management Services

Dedicator of cytokinesis 8 (DOCK8) mutation impairs the differentiation of helper T cells by regulating the glycolytic pathway of CD4+ T cells

Clinical, immunological, and genetic description of a Mexican cohort of patients with DOCK8 deficiency

The Protein Kinase C βII Exon Confers mRNA Instability in the Presence of High Glucose Concentrations*

DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients

A novel homozygous DOCK8 mutation associated with unusual coexistence of gross molluscum contagiosum and epidermodysplasia verruciformis in a DOCK8 deficiency patient.

Single-Cell Transcriptomics Reveals a Pivotal Role of DOCK2 in Sjögren Disease

DOCK8 Mutation in Patient with Juvenile Idiopathic Arthritis and Sjögren's Syndrome

Characterization and cloning of an (R)-specific trans-2,3-enoylacyl-CoA hydratase from Rhodospirillum rubrum and use of this enzyme for PHA production in Escherichia coli

Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy

Hyper-IgE Syndrome Caused by DOCK8 Mutation with a Tumour-Like Lesion of the Lip: a Case Report

Role of DOCK8 in cytokine storm syndromes

DOCK8 gene mutation alters cell subsets, BCR signaling, and cell metabolism in B cells

The role of reconstructive surgery in the management of war wounds.

The regulation of DOCK family proteins on T and B cells

A case of trichodysplasia spinulosa related to ruxolitinib treated successfully with oral acitretin

Idiopathic multicentric Castleman disease and connective tissue disorder successfully treated by siltuximab: a pediatric case report

Combined immunodeficiency with marginal zone lymphoma due to a novel homozygous mutation in IL-21R gene and successful treatment with hematopoietic stem cell transplantation

DOCK2-deficiency causes defects in anti-viral T cell responses and impaired control of herpes simplex virus infection